Showing 1,321 - 1,340 results of 159,008 for search '(( 2 a decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (we decrease)) ))', query time: 2.00s Refine Results
  1. 1321

    GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

    Published 2021
    “…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”
  2. 1322
  3. 1323
  4. 1324
  5. 1325

    Top 10 transcripts with decreased ribosome density and their function (see also S2 Table). by Nahuel A. Paolini (5081699)

    Published 2018
    “…<p>Top 10 transcripts with decreased ribosome density and their function (see also <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0193790#pone.0193790.s010" target="_blank">S2 Table</a>).…”
  6. 1326
  7. 1327
  8. 1328
  9. 1329

    of decreased GFR by age and gender. by Hui Song (53547)

    Published 2014
    “…<p>GFR, glomerular filtration rate. Decreased GFR was defined as an estimated glomerular filtration rate <60 ml/min per 1.73 m<sup>2</sup> according to a formula developed by adaptation of the Modification of the Diet Renal Disease (MDRD) equation on the basis of data from Chinese chronic kidney disease patients.…”
  10. 1330

    Hydrolysis Stability of Bidentate Phosphites Utilized as Modifying Ligands in the Rh-Catalyzed <i>n</i>‑Regioselective Hydroformylation of Olefins by Baoxin Zhang (1570096)

    Published 2016
    “…These modifications of <b>L1</b> also give rise to different catalytic performances in the <i>n</i>-regioselective hydroformylation of <i>n</i>-octenes and 2-pentene, from which the 3,5-di-<i>t</i>-butyl-substituted ligand offered a higher <i>n</i>-regioselectivity accompanied by a lowering of the reaction rate in comparison to the parent ligand <b>L1</b>.…”
  11. 1331

    Hydrolysis Stability of Bidentate Phosphites Utilized as Modifying Ligands in the Rh-Catalyzed <i>n</i>‑Regioselective Hydroformylation of Olefins by Baoxin Zhang (1570096)

    Published 2016
    “…These modifications of <b>L1</b> also give rise to different catalytic performances in the <i>n</i>-regioselective hydroformylation of <i>n</i>-octenes and 2-pentene, from which the 3,5-di-<i>t</i>-butyl-substituted ligand offered a higher <i>n</i>-regioselectivity accompanied by a lowering of the reaction rate in comparison to the parent ligand <b>L1</b>.…”
  12. 1332

    Hydrolysis Stability of Bidentate Phosphites Utilized as Modifying Ligands in the Rh-Catalyzed <i>n</i>‑Regioselective Hydroformylation of Olefins by Baoxin Zhang (1570096)

    Published 2016
    “…These modifications of <b>L1</b> also give rise to different catalytic performances in the <i>n</i>-regioselective hydroformylation of <i>n</i>-octenes and 2-pentene, from which the 3,5-di-<i>t</i>-butyl-substituted ligand offered a higher <i>n</i>-regioselectivity accompanied by a lowering of the reaction rate in comparison to the parent ligand <b>L1</b>.…”
  13. 1333

    Hydrolysis Stability of Bidentate Phosphites Utilized as Modifying Ligands in the Rh-Catalyzed <i>n</i>‑Regioselective Hydroformylation of Olefins by Baoxin Zhang (1570096)

    Published 2016
    “…These modifications of <b>L1</b> also give rise to different catalytic performances in the <i>n</i>-regioselective hydroformylation of <i>n</i>-octenes and 2-pentene, from which the 3,5-di-<i>t</i>-butyl-substituted ligand offered a higher <i>n</i>-regioselectivity accompanied by a lowering of the reaction rate in comparison to the parent ligand <b>L1</b>.…”
  14. 1334
  15. 1335

    a-c: Bone marrow (BM) HIF2 α is inappropriately decreased in uremic anemia. by Daniel Landau (440830)

    Published 2018
    “…<p>BM HIF2 α protein (depicted as percentage of actin-corrected concentration) increases in 7 day-bled rats (Fig 2a) Vs control. …”
  16. 1336
  17. 1337
  18. 1338
  19. 1339

    DataSheet_1_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.zip by Xiao-yang Gong (13103400)

    Published 2022
    “…A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”
  20. 1340